Clinical Trial: First in Patient Study for PF-06840003 in Malignant Gliomas

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Phase 1 Dose Escalation Study Evaluating The Safety And Tolerability Of Pf-06840003 In Patients With Malignant Gliomas

Brief Summary: This study will evaluate the safety and tolerability of increasing doses of PF-06840003 in patients with malignant gliomas.